Snowball logo
logo
AUPH

Aurinia Pharmaceuticals Inc

$15.94-$0.16ย  (0.99%)

Frequently asked questions

What sector does Aurinia Pharmaceuticals Inc (AUPH) operate in?

Aurinia Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Aurinia Pharmaceuticals Inc (AUPH) current stock price?

As of the latest data, Aurinia Pharmaceuticals Inc stock price is $15.94, with a previous close of $16.10. Aurinia Pharmaceuticals Inc lost -$0.16 in the last trading session, representing a -0.99% loss.

What is Aurinia Pharmaceuticals Inc (AUPH) current market capitalization?

Aurinia Pharmaceuticals Inc market cap is approximately 2.05 billion.

What is Aurinia Pharmaceuticals Inc (AUPH) Earnings Per Share (EPS)?

The trailing EPS is $2.16, and the forward EPS is $1.12.

What is Aurinia Pharmaceuticals Inc (AUPH) Price-to-Earnings (P/E) ratio?

Aurinia Pharmaceuticals Inc current P/E ratio is 7.38, with a forward P/E of 14.26.

What is Aurinia Pharmaceuticals Inc (AUPH) EBITDA?

Aurinia Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 49.75 million.

Does Aurinia Pharmaceuticals Inc (AUPH) pay dividends?

No. Aurinia Pharmaceuticals Inc does not pay a dividend.

How did Aurinia Pharmaceuticals Inc (AUPH) perform in its most recent earnings report?

In the last report (March 31, 2026), Aurinia Pharmaceuticals Inc posted an EPS surprise of 56.25% and a revenue surprise of 0.94%.

When is Aurinia Pharmaceuticals Inc (AUPH) next earnings report?

Aurinia Pharmaceuticals Inc is expected to release its next earnings report on June 30, 2026.

What is Aurinia Pharmaceuticals Inc (AUPH) beta (volatility) score?

Aurinia Pharmaceuticals Inc has a beta of 1.434, suggesting it is more volatile than the market.